HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yuange He Selected Research
Yuange He Research Topics
Disease
3
Adenocarcinoma of Lung
01/2024 - 01/2022
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 08/2022
3
Neoplasms (Cancer)
01/2024 - 01/2022
1
Breast Neoplasms (Breast Cancer)
08/2022
1
Lung Neoplasms (Lung Cancer)
08/2022
1
Brain Neoplasms (Brain Tumor)
01/2022
1
Head and Neck Neoplasms (Head and Neck Cancer)
01/2021
1
Parotid Neoplasms
01/2021
Drug/Important Bio-Agent (IBA)
3
ErbB Receptors (EGF Receptor)
IBA
01/2024 - 01/2022
3
Tyrosine Kinase Inhibitors
IBA
01/2024 - 01/2022
2
Crizotinib
IBA
01/2022 - 01/2021
1
osimertinib
IBA
01/2024
1
Bevacizumab (Avastin)
FDA Link
01/2024
1
Immune Checkpoint Inhibitors
IBA
08/2022
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
08/2022
1
sintilimab
IBA
08/2022
1
niraparib
IBA
08/2022
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
08/2022
1
Pemetrexed (MTA)
FDA Link
01/2022
1
Tropomyosin
IBA
01/2021
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2021
Therapy/Procedure
2
Drug Therapy (Chemotherapy)
08/2022 - 01/2022
2
Therapeutics
08/2022 - 01/2022
1
Immunotherapy
08/2022
1
Molecular Targeted Therapy
08/2022